Does the media favor AMWL or HIT?

In the previous week, Health In Tech had 1 more articles in the media than American Well. MarketBeat recorded 12 mentions for Health In Tech and 11 mentions for American Well. American Well's average media sentiment score of 0.53 beat Health In Tech's score of -0.33 indicating that American Well is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment American Well 5 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Health In Tech 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings & valuation, OPRX or HIT?

OptimizeRx has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OptimizeRx $109.43M 1.43 $5.13M $0.23 36.00 Health In Tech $32.83M 1.48 -$4.59M -$0.07 N/A

Does the media prefer OPRX or HIT?

In the previous week, Health In Tech had 10 more articles in the media than OptimizeRx. MarketBeat recorded 12 mentions for Health In Tech and 2 mentions for OptimizeRx. OptimizeRx's average media sentiment score of 0.30 beat Health In Tech's score of -0.33 indicating that OptimizeRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OptimizeRx 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Health In Tech 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor HCAT or HIT?

In the previous week, Health In Tech had 10 more articles in the media than Health Catalyst. MarketBeat recorded 12 mentions for Health In Tech and 2 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.00 beat Health In Tech's score of -0.33 indicating that Health Catalyst is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Health In Tech 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer CCLD or HIT?

Health In Tech has a consensus target price of $3.50, indicating a potential upside of 373.10%. Given Health In Tech's stronger consensus rating and higher probable upside, analysts clearly believe Health In Tech is more favorable than CareCloud. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CareCloud 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Health In Tech 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67

Which has better earnings & valuation, CCLD or HIT?

CareCloud has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareCloud $128.64M 0.66 $10.80M $0.07 28.57 Health In Tech $32.83M 1.48 -$4.59M -$0.07 N/A

Health In Tech (HIT) Competitors

$0.74 -0.01 (-1.27%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$0.72 -0.02 (-2.81%)

As of 10/9/2026 06:45 PM Eastern

Compare

HIT vs. AMWL, OPRX, HCAT, DH, and CCLD

Should you buy Health In Tech stock or one of its competitors? Health In Tech's main competitors and comparable companies include American Well (AMWL), OptimizeRx (OPRX), Health Catalyst (HCAT), Definitive Healthcare (DH), and CareCloud (CCLD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Health In Tech compare to American Well?

American Well (NYSE:AMWL) and Health In Tech (NASDAQ:HIT) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

Health In Tech has a net margin of 0.00% compared to American Well's net margin of -35.75%. Health In Tech's return on equity of 0.00% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-35.75%	-30.12%	-22.30%
Health In Tech	N/A	N/A	N/A

American Well has a beta of 1.67, indicating that its stock price is 67% more volatile than the broader market. Comparatively, Health In Tech has a beta of 2.81, indicating that its stock price is 181% more volatile than the broader market.

Health In Tech has lower revenue, but higher earnings than American Well. Health In Tech is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.84	-$95.70M	-$4.77	N/A
Health In Tech	$32.83M	1.48	-$4.59M	-$0.07	N/A

American Well currently has a consensus price target of $9.50, indicating a potential downside of 25.00%. Health In Tech has a consensus price target of $3.50, indicating a potential upside of 373.10%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts clearly believe Health In Tech is more favorable than American Well.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

56.1% of American Well shares are held by institutional investors. 12.8% of American Well shares are held by insiders. Comparatively, 77.7% of Health In Tech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Health In Tech had 1 more articles in the media than American Well. MarketBeat recorded 12 mentions for Health In Tech and 11 mentions for American Well. American Well's average media sentiment score of 0.53 beat Health In Tech's score of -0.33 indicating that American Well is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
American Well	5 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Health In Tech	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Health In Tech beats American Well on 12 of the 16 factors compared between the two stocks.

How does Health In Tech compare to OptimizeRx?

OptimizeRx (NASDAQ:OPRX) and Health In Tech (NASDAQ:HIT) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

OptimizeRx has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43M	1.43	$5.13M	$0.23	36.00
Health In Tech	$32.83M	1.48	-$4.59M	-$0.07	N/A

In the previous week, Health In Tech had 10 more articles in the media than OptimizeRx. MarketBeat recorded 12 mentions for Health In Tech and 2 mentions for OptimizeRx. OptimizeRx's average media sentiment score of 0.30 beat Health In Tech's score of -0.33 indicating that OptimizeRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OptimizeRx	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Health In Tech	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

OptimizeRx has a net margin of 4.66% compared to Health In Tech's net margin of 0.00%. OptimizeRx's return on equity of 9.44% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OptimizeRx	4.66%	9.44%	7.11%
Health In Tech	N/A	N/A	N/A

76.5% of OptimizeRx shares are owned by institutional investors. 7.5% of OptimizeRx shares are owned by company insiders. Comparatively, 77.7% of Health In Tech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

OptimizeRx currently has a consensus target price of $11.57, indicating a potential upside of 39.75%. Health In Tech has a consensus target price of $3.50, indicating a potential upside of 373.10%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts clearly believe Health In Tech is more favorable than OptimizeRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

OptimizeRx has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market. Comparatively, Health In Tech has a beta of 2.81, suggesting that its share price is 181% more volatile than the broader market.

Summary

OptimizeRx beats Health In Tech on 10 of the 17 factors compared between the two stocks.

How does Health In Tech compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and Health In Tech (NASDAQ:HIT) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

Health In Tech has a net margin of 0.00% compared to Health Catalyst's net margin of -90.61%. Health In Tech's return on equity of 0.00% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health Catalyst	-90.61%	-1.83%	-0.80%
Health In Tech	N/A	N/A	N/A

85.0% of Health Catalyst shares are held by institutional investors. 19.4% of Health Catalyst shares are held by company insiders. Comparatively, 77.7% of Health In Tech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Health Catalyst has a beta of 1.54, suggesting that its stock price is 54% more volatile than the broader market. Comparatively, Health In Tech has a beta of 2.81, suggesting that its stock price is 181% more volatile than the broader market.

In the previous week, Health In Tech had 10 more articles in the media than Health Catalyst. MarketBeat recorded 12 mentions for Health In Tech and 2 mentions for Health Catalyst. Health Catalyst's average media sentiment score of 0.00 beat Health In Tech's score of -0.33 indicating that Health Catalyst is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Health Catalyst	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Health In Tech	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Health Catalyst presently has a consensus target price of $2.15, suggesting a potential upside of 21.47%. Health In Tech has a consensus target price of $3.50, suggesting a potential upside of 373.10%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts clearly believe Health In Tech is more favorable than Health Catalyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health Catalyst	1 Sell rating(s)	6 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.11
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Health In Tech has lower revenue, but higher earnings than Health Catalyst. Health In Tech is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health Catalyst	$311.14M	0.43	-$177.97M	-$3.68	N/A
Health In Tech	$32.83M	1.48	-$4.59M	-$0.07	N/A

Summary

Health In Tech beats Health Catalyst on 12 of the 17 factors compared between the two stocks.

How does Health In Tech compare to Definitive Healthcare?

Health In Tech (NASDAQ:HIT) and Definitive Healthcare (NASDAQ:DH) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

Health In Tech currently has a consensus price target of $3.50, indicating a potential upside of 373.10%. Definitive Healthcare has a consensus price target of $1.47, indicating a potential upside of 50.15%. Given Health In Tech's stronger consensus rating and higher possible upside, equities analysts plainly believe Health In Tech is more favorable than Definitive Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Definitive Healthcare	3 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	1.90

98.7% of Definitive Healthcare shares are held by institutional investors. 77.7% of Health In Tech shares are held by insiders. Comparatively, 17.1% of Definitive Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Health In Tech has a net margin of 0.00% compared to Definitive Healthcare's net margin of -72.28%. Definitive Healthcare's return on equity of 3.55% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Definitive Healthcare	-72.28%	3.55%	1.63%

Health In Tech has a beta of 2.81, suggesting that its share price is 181% more volatile than the broader market. Comparatively, Definitive Healthcare has a beta of 1.4, suggesting that its share price is 40% more volatile than the broader market.

Health In Tech has higher earnings, but lower revenue than Definitive Healthcare. Health In Tech is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Health In Tech	$32.83M	1.48	-$4.59M	-$0.07	N/A
Definitive Healthcare	$232.70M	0.45	-$138.93M	-$1.60	N/A

In the previous week, Health In Tech had 11 more articles in the media than Definitive Healthcare. MarketBeat recorded 12 mentions for Health In Tech and 1 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.00 beat Health In Tech's score of -0.33 indicating that Definitive Healthcare is being referred to more favorably in the news media.

Company	Overall Sentiment
Health In Tech	Neutral
Definitive Healthcare	Neutral

Summary

Health In Tech beats Definitive Healthcare on 10 of the 16 factors compared between the two stocks.

How does Health In Tech compare to CareCloud?

CareCloud (NASDAQ:CCLD) and Health In Tech (NASDAQ:HIT) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

In the previous week, Health In Tech had 11 more articles in the media than CareCloud. MarketBeat recorded 12 mentions for Health In Tech and 1 mentions for CareCloud. CareCloud's average media sentiment score of 0.00 beat Health In Tech's score of -0.33 indicating that CareCloud is being referred to more favorably in the media.

Company	Overall Sentiment
CareCloud	Neutral
Health In Tech	Neutral

CareCloud has a beta of 1.51, indicating that its share price is 51% more volatile than the broader market. Comparatively, Health In Tech has a beta of 2.81, indicating that its share price is 181% more volatile than the broader market.

CareCloud has higher revenue and earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$128.64M	0.66	$10.80M	$0.07	28.57
Health In Tech	$32.83M	1.48	-$4.59M	-$0.07	N/A

Health In Tech has a consensus target price of $3.50, indicating a potential upside of 373.10%. Given Health In Tech's stronger consensus rating and higher probable upside, analysts clearly believe Health In Tech is more favorable than CareCloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Health In Tech	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

CareCloud has a net margin of 6.21% compared to Health In Tech's net margin of 0.00%. CareCloud's return on equity of 27.07% beat Health In Tech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	6.21%	27.07%	14.56%
Health In Tech	N/A	N/A	N/A

10.2% of CareCloud shares are owned by institutional investors. 14.8% of CareCloud shares are owned by company insiders. Comparatively, 77.7% of Health In Tech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

CareCloud beats Health In Tech on 9 of the 16 factors compared between the two stocks.

Get Health In Tech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIT vs. The Competition

Export

Metric	Health In Tech	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$49.11M	$1.81B	$7.17B	$13.21B
Dividend Yield	N/A	3.96%	2.53%	16.37%
P/E Ratio	-10.57	21.78	274.15	26.16
Price / Sales	1.48	95.30	635.99	107.44
Price / Cash	N/A	31.98	76.38	53.09
Price / Book	N/A	6.25	11.22	6.33
Net Income	N/A	-$19.09M	$3.50B	$382.15M
7 Day Performance	-5.57%	-0.80%	-0.90%	-1.40%
1 Month Performance	-20.52%	1.00%	-4.44%	-3.47%
1 Year Performance	-78.37%	-19.78%	7.02%	1.19%

Health In Tech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIT Health In Tech	2.7988 of 5 stars	$0.74 -1.3%	$3.50 +373.1%	-78.5%	$49.11M	$32.83M	N/A	91	Analyst Revision Gap Down
AMWL American Well	2.1025 of 5 stars	$13.36 -0.8%	$9.50 -28.9%	+105.3%	$222.29M	$218.53M	N/A	562
OPRX OptimizeRx	3.708 of 5 stars	$8.04 +1.9%	$11.43 +42.1%	-54.7%	$151.44M	$98.65M	34.96	105	High Trading Volume
HCAT Health Catalyst	2.8511 of 5 stars	$1.74 flat	$2.45 +40.8%	-36.3%	$130.95M	$292.25M	N/A	1,200
DH Definitive Healthcare	2.8415 of 5 stars	$0.95 -6.4%	$1.47 +55.7%	-68.2%	$100.87M	$232.70M	N/A	686	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HIT) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Health In Tech (HIT) Competitors

HIT vs. AMWL, OPRX, HCAT, DH, and CCLD

How does Health In Tech compare to American Well?

Summary

How does Health In Tech compare to OptimizeRx?

Summary

How does Health In Tech compare to Health Catalyst?

Summary

How does Health In Tech compare to Definitive Healthcare?

Summary

How does Health In Tech compare to CareCloud?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIT vs. The Competition

Health In Tech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Health In Tech (HIT) Competitors

HIT vs. AMWL, OPRX, HCAT, DH, and CCLD

How does Health In Tech compare to American Well?

Is AMWL or HIT more profitable?

Which has more volatility & risk, AMWL or HIT?

Which has stronger earnings and valuation, AMWL or HIT?

Do analysts rate AMWL or HIT?

Do institutionals and insiders believe in AMWL or HIT?

Does the media favor AMWL or HIT?

Summary

How does Health In Tech compare to OptimizeRx?

Which has better earnings & valuation, OPRX or HIT?

Does the media prefer OPRX or HIT?

Is OPRX or HIT more profitable?

Do institutionals & insiders believe in OPRX or HIT?

Do analysts recommend OPRX or HIT?

Which has more volatility & risk, OPRX or HIT?

Summary

How does Health In Tech compare to Health Catalyst?

Is HCAT or HIT more profitable?

Do institutionals and insiders hold more shares of HCAT or HIT?

Which has more volatility and risk, HCAT or HIT?

Does the media favor HCAT or HIT?

Do analysts recommend HCAT or HIT?

Which has higher earnings & valuation, HCAT or HIT?

Summary

How does Health In Tech compare to Definitive Healthcare?

Do analysts recommend HIT or DH?

Do insiders and institutionals have more ownership in HIT or DH?

Is HIT or DH more profitable?

Which has more volatility & risk, HIT or DH?

Which has preferable earnings & valuation, HIT or DH?

Does the media refer more to HIT or DH?

Summary

How does Health In Tech compare to CareCloud?

Does the media prefer CCLD or HIT?

Which has more volatility & risk, CCLD or HIT?

Which has better earnings & valuation, CCLD or HIT?

Do analysts prefer CCLD or HIT?

Is CCLD or HIT more profitable?

Do insiders & institutionals have more ownership in CCLD or HIT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIT vs. The Competition

Health In Tech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools